The use of iATP in the atrium may similarly enhance termination of atrial arrhythmias, avoiding prolonged arrhythmia burden or need for cardioversion. Objective: To compare efficacy of 3 atrial ATP protocols (PROT[GS1] ) in either converting AFL to sinus rhythm or accelerating AFL to atrial ...
Digitalis has long been used as an antiarrhythmic drug in treatment of paroxysmal supraventricular tachycardia, atrial fibrillation and flutter, and arrhythmias associated with congestive heart failure. However, newer evidence indicates that this cardiac glycoside has limited potency as an antiarrhythmic drug...
Acute management of atrial fibrillation and atrial flutter in the critical care unit: should it be ibutilide? Background: Ibutilide is currently indicated for the rapid conversion of atrial fibrillation (Afb) or atrial flutter (Afl) of recent onset but limited to p... P Varriale,A Sedighi ...
Introduction The ILCOR Pediatric Task Force included expert reviewers from Africa, Asia, Australia, Asia, Europe, North America, and South America. These e... en - 《Circulation》 被引量: 52发表: 2005年 Abnormal troponin level as short-term predictor of poor outcome in acute atrial fibrillation...
Prophylaxis and Management of Postoperative Atrial Fibrillation and Flutter in Patients Undergoing Surgery for Coronary Artery Disease and Valvular Heart DiseaseNo Abstractdoi:10.1016/j.hlc.2018.06.745Connell, C.HEART LUNG AND CIRCULATION
Variation in emergency department management of recent-onset atrial fibrillation and flutter (RAFF)I.G., StiellC., ClementR., BrisonB.H., RoweB., BorgundvaagT., LanghanE., LangK., MageeR., StenstromJ., Perry
SGLT2 inhibitors also reduced the risk of cardiac arrhythmias and atrial fibrillation/atrial flutter progression [54, 55]. Currently, the approved SGLT2 inhibitors are empagliflozin [56], canagliflozin [57], dapagliflozin [58], ertugliflozin [59], tofogliflozin [60], luseogliflozin [61] and ...
Fromm C, Suau S, Cohen V, Jellinek S, Likourezos A, Rose J, Marshall J. Comparison of diltiazem and metoprolol in the management of atrial fibrillation or flutter with rapid ventricular rate in the emergency department: a prospective, randomized double-blind trial [abst...
The pharmacological management of disease should involve consideration of the balance between the beneficial effects of treatment on outcome and the probab
In addition, a decrease in mortality due to cancer and CVD in older people with T2DM in Australia was observed, masking the rising excess risk among patients of younger ages [27]. There is a suggestion that younger-onset T2DM may be associated with an increase in CVD-related mortality but ...